SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-24-000154
Filing Date
2024-01-25
Accepted
2024-01-25 11:11:16
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING REGENERON PHARMACEUTICALS, INC. REGENERON_PHARMACEUTICALS_.htm SC 13G/A 88608
  Complete submission text file 0000019617-24-000154.txt   90610
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Subject) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-41938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)